Skip to main content

Israel Molina Romero

Sóc metge i responsable de la Unitat de Medicina Tropical i Salut Internacional

Institutions of which they are part

Head of group
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Israel Molina Romero

Institutions of which they are part

Head of group
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Sóc metge i responsable de la Unitat de Medicina Tropical i Salut Internacional

Llicenciat en Medicina per la UAB. Adjunt del Servei de Malalties Infeccioses Hospital Universitari Vall d'Hebron. Responsable de la Unitat de Medicina Tropical i Salut Internacional de l'Hospital Vall d'Hebron. Director del Programa de Salut Internacional de l'ICS. Experiència clínica i de recerca a Guinea Ecuatorial, Brasil i Angola.

Projects

Red de Investigación Cooperativa en Enfermedades Tropicales RICET

IP: Israel Molina Romero
Collaborators: Jose Santos Santiago, Antoni Soriano Arandes, Diana Pou Ciruelo, Begoña Treviño Maruri, Nuria Serre Delcor, Fernando M Salvador Velez, Augusto Cesar Sao Aviles, Jordi Gómez i Prat, Raisa Morales Martinez, Adrián Sánchez Montalvá, Elena Sulleiro Igual
Funding agency: Instituto de Salud Carlos III
Funding: 143525
Reference: RD12/0018/0020
Duration: 01/01/2013 - 30/09/2017

Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas disease (BERENICE) Grant Agreement nº 305937

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Núria Pérez Picazo, Fernando M Salvador Velez, Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas disease (BERENICE) Grant Agreement nº 305937, Adrián Sánchez Montalvá, Elena Sulleiro Igual, Olga Sánchez- Maroto Carrizo, Esperanza Esteban Serna
Funding agency: EUROPEAN COMMISSION
Funding: 939958.88
Reference: BERENICE_FP7HEALTH2012
Duration: 01/09/2012 - 31/08/2018

Estudio prospectivo para el cribado de la infección tuberculosa latente en población inmigrante mediante la prueba de la tuberculina y Quantiferon

IP: Israel Molina Romero
Collaborators: Jose Angel Rodrigo Pendás, Begoña Treviño Maruri, Fernando M Salvador Velez, Mª Teresa Tórtola Fernández, Adrián Sánchez Montalvá
Funding agency: Instituto de Salud Carlos III
Funding: 35392.5
Reference: PI11/01503
Duration: 01/01/2012 - 30/06/2016

iNTER Support Action (International Network of Teleconsultation Excellence & Referral (iSA) Grant Agreement nº 223610

IP: Israel Molina Romero
Collaborators: Vicenç Falcó Ferrer
Funding agency: EUROPEAN COMMISSION
Funding: 33590
Reference: ISA 223610 FP7 HEALTH 2007
Duration: 01/09/2009 - 29/02/2012

Related news

AIDAY 2026 showcased the artificial intelligence initiatives, infrastructures and projects already being developed across the Campus.

All patients showed a favorable clinical course and responded well to antibiotic treatment, without complications.

The study results show that the local presence of IL-1β promotes the development of myeloid cells with an immunosuppressive function.

Related professionals

Sofía Travers Rama

Sofía Travers Rama

Predoctoral researcher
Gene and Cell Therapy
Read more
Pamela Torrano Soler

Pamela Torrano Soler

Gestió i Administració
Clinical Research Development Directorate
Read more
Marta Rodríguez Aliberas

Marta Rodríguez Aliberas

Postdoctoral researcher
Transfusional Medicine
Read more
Marc Patricio Liebana

Marc Patricio Liebana

Predoctoral researcher
Nephrology and kidney transplantation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.